Toshima-ku, Japan

Toshiharu Shimazaki



 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2011-2012

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Toshiharu Shimazaki

Introduction

Toshiharu Shimazaki is a prominent inventor based in Toshima-ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing therapeutic agents for various mental and physical health conditions. With a total of 3 patents to his name, Shimazaki's work is recognized for its potential impact on healthcare.

Latest Patents

One of Shimazaki's latest patents involves phenylpyrazole derivatives. This invention provides a prophylactic or therapeutic agent for a range of conditions, including dementia, Alzheimer's disease, attention-deficit hyperactivity disorder, schizophrenia, eating disorders, obesity, diabetes, hyperlipidemia, sleep disorders, narcolepsy, sleep apnea syndrome, circadian rhythm disorder, depression, and allergic rhinitis. The patent details a phenylpyrazole derivative represented by a specific formula, which may include pharmaceutically acceptable salts.

Career Highlights

Shimazaki is currently associated with Taisho Pharmaceutical Co., Ltd., where he continues to innovate and develop new therapeutic solutions. His work is characterized by a commitment to addressing complex health issues through scientific research and development.

Collaborations

Throughout his career, Shimazaki has collaborated with notable colleagues, including Toshio Nakamura and Makoto Tatsuzuki. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Toshiharu Shimazaki's contributions to the field of pharmaceuticals exemplify the importance of innovation in addressing health challenges. His work on phenylpyrazole derivatives showcases his dedication to improving patient outcomes through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…